Earth Science Tech, Inc. ETST revenue by segment, product and geography
In its fiscal year ending 2026-03-31, Earth Science Tech, Inc. reported revenue across 3 products and services; the largest, Sale Of Pharmaceutical Products And Medical Consultations, was $32.9M, 92.2% of the filed sum (+9.6% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Sale Of Pharmaceutical Products And Medical Consultations$32.9M92.2%+9.6% yoy
- Shipping And Handling$2.49M7.0%-19.6% yoy
- Other Revenue$301K0.8%no prior
Members sum to the consolidated $35.7M for this period.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.